Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
- PMID: 33227939
- PMCID: PMC7699148
- DOI: 10.3390/life10110290
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening
Abstract
The human papillomavirus is one of the most common sexually transmitted viruses, and an infection from this virus may become persistent, leading to diseases such as cervical cancer. In the past, cytology-based methods such as the Papanicolaou (Pap) test were imperative to identify the disease at a stage where it can be treated. However, since the 1980s where the etiological association of HPV and cervical cancer was identified, new tests began emerging directed towards identifying the virus. Furthermore, as the biology of HPV along with the relationships with its host are elucidated, these tests and treatments further advance. Recently in Europe, there is a movement towards the implementation of HPV testing methodologies in national screening programs to precede cytological testing. These screening strategies are recommended by the European guidelines and the World Health Organization. This review presents the current HPV testing methodologies, their application in organized population-based cervical cancer screening programs based on the most recent European guidelines, and their implementation status in countries in Europe.
Keywords: HPV testing; cervical cancer; human papillomavirus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Anal dysplasia screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(4):1-43. Epub 2007 Jun 1. Ont Health Technol Assess Ser. 2007. PMID: 23074504 Free PMC article.
-
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Epidemiol Prev. 2012. PMID: 22828243 Italian.
-
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.Clin Microbiol Infect. 2020 May;26(5):579-583. doi: 10.1016/j.cmi.2019.09.006. Epub 2019 Sep 17. Clin Microbiol Infect. 2020. PMID: 31539637 Review.
-
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Vaccine. 2008. PMID: 18847555 Review.
-
[Cervical cancer screening: past--present--future].Pathologe. 2009 Dec;30 Suppl 2:128-35. doi: 10.1007/s00292-009-1189-1. Pathologe. 2009. PMID: 19756616 German.
Cited by
-
Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.PLoS One. 2023 Jan 19;18(1):e0280437. doi: 10.1371/journal.pone.0280437. eCollection 2023. PLoS One. 2023. PMID: 36656844 Free PMC article.
-
Diagnostic Three Slides Pap Test Compared to Punch Biopsy and Endocervical Curettage in Confirmed HSIL+ Diagnosis.Diagnostics (Basel). 2021 May 25;11(6):942. doi: 10.3390/diagnostics11060942. Diagnostics (Basel). 2021. PMID: 34070458 Free PMC article.
-
Worldwide initiatives to eliminate cervical cancer.Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):102-106. doi: 10.1002/ijgo.13879. Int J Gynaecol Obstet. 2021. PMID: 34669201 Free PMC article.
-
Predictive value of 'Smartscopy' for the detection of preinvasive cervical lesions during the COVID-19 pandemic: a diagnostic study.Obstet Gynecol Sci. 2022 Sep;65(5):451-458. doi: 10.5468/ogs.22092. Epub 2022 Jul 28. Obstet Gynecol Sci. 2022. PMID: 35902246 Free PMC article.
-
Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.Microbiol Spectr. 2023 Aug 17;11(4):e0008123. doi: 10.1128/spectrum.00081-23. Epub 2023 Jun 7. Microbiol Spectr. 2023. PMID: 37284753 Free PMC article.
References
-
- Bowden S.J., Kyrgiou M. Human papillomavirus. Obstet. Gynaecol. Reprod. Med. 2020;30:109–118. doi: 10.1016/j.ogrm.2020.02.003. - DOI
-
- Vos R.A., Pasmans H., Tymchenko L., Janga-Jansen A.V.A., Baboe-Kalpoe S., Hulshof K., de Melker H.E., van der Klis F.R.M. High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands. Vaccine. 2020;38:2816–2826. doi: 10.1016/j.vaccine.2020.02.017. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous